37,136 Shares in Oscar Health, Inc. $OSCR Acquired by AXQ Capital LP

Key Points

• AXQ Capital LP acquired 37,136 Oscar Health shares in the second quarter, valued at approximately $1.06 million. Institutional investors collectively own 75.70% of the company.
• Oscar Health reported strong quarterly results, with earnings of $1.10 per share versus a $0.40 consensus estimate and revenue of $4.88 billion, up 70.4% year over year.
• Analyst sentiment remains mixed: the stock has a consensus “Hold” rating and a $26.22 price target, while shares recently opened at $32.20; insiders have sold $124.3 million in stock over the past 90 days.

AXQ Capital LP bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 37,136 shares of the company's stock, valued at approximately $1,059,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in OSCR. Geode Capital Management LLC lifted its holdings in Oscar Health by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company's stock worth $68,964,000 after buying an additional 116,430 shares in the last quarter. BIT Capital GmbH grew its stake in shares of Oscar Health by 545.0% in the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company's stock worth $88,897,000 after acquiring an additional 5,227,152 shares in the last quarter. Simplify Asset Management Inc. acquired a new position in shares of Oscar Health in the fourth quarter worth $2,948,000. Fortis Group Advisors LLC increased its position in shares of Oscar Health by 82.9% during the fourth quarter. Fortis Group Advisors LLC now owns 189,857 shares of the company's stock worth $2,724,000 after acquiring an additional 86,035 shares during the period. Finally, Convergence Investment Partners LLC purchased a new stake in shares of Oscar Health during the first quarter worth $1,208,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Stock Performance

Shares of OSCR opened at $32.20 on Friday. The stock has a 50 day moving average price of $30.43 and a 200 day moving average price of $22.68. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $9.94 billion, a price-to-earnings ratio of 23.00, a price-to-earnings-growth ratio of 0.66 and a beta of 2.37. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $33.55.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company had revenue of $4.88 billion for the quarter, compared to analysts' expectations of $4.73 billion. During the same quarter last year, the company earned ($0.89) earnings per share. The firm's revenue for the quarter was up 70.4% on a year-over-year basis. Research analysts predict that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Analysts Set New Price Targets

OSCR has been the topic of several recent research reports. Weiss Ratings upgraded Oscar Health from a "sell (d+)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. Wells Fargo & Company lifted their price objective on Oscar Health from $20.00 to $27.00 and gave the company an "equal weight" rating in a research note on Thursday, August 13th. Zacks Research raised Oscar Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 6th. Wall Street Zen upgraded shares of Oscar Health from a "buy" rating to a "strong-buy" rating in a research note on Sunday, June 14th. Finally, Barclays raised their target price on shares of Oscar Health from $35.00 to $39.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $26.22.

Insider Activity at Oscar Health

In related news, CEO Mark Bertolini sold 624,244 shares of Oscar Health stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $28.48, for a total transaction of $17,778,469.12. Following the sale, the chief executive officer directly owned 7,751,570 shares in the company, valued at $220,764,713.60. This trade represents a 7.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Blackley sold 18,750 shares of the business's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $31.74, for a total transaction of $595,125.00. Following the completion of the sale, the chief financial officer directly owned 56,250 shares of the company's stock, valued at approximately $1,785,375. This trade represents a 25.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 4,241,556 shares of company stock valued at $124,280,299 in the last ninety days. Insiders own 22.64% of the company's stock.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.